Infectious Disease in Minneapolis, MN
8 verified infectious disease doctors in Minneapolis.
Infectious disease physicians diagnose and manage complex infections, including those that are chronic, resistant, or hard to identify.
NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.
Dr. Ganeshan Raveendran, MD
Infectious Disease
CMS Open Payments· $2,146 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$2,146
Total received
19
Transactions
7
Paying companies
Top paying companies
Among the 3,681 infectious disease doctors we've analyzed, about 83% received any industry payment (median $1,189 among those who did). This doctor's total ranks around the 70th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US infectious disease doctors.
Payments to Ganeshan Raveendran do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Michael Mooney, MD
Infectious Disease
CMS Open Payments· $20,629 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$20,629
Total received
2
Transactions
2
Paying companies
Top paying companies
Among the 3,681 infectious disease doctors we've analyzed, about 83% received any industry payment (median $1,189 among those who did). This doctor's total is higher than 91% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US infectious disease doctors.
Payments to Michael Mooney do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Michael Manoles, MD
Infectious Disease
CMS Open Payments· $27,890 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$27,890
Total received
37
Transactions
4
Paying companies
Top paying companies
Among the 3,681 infectious disease doctors we've analyzed, about 83% received any industry payment (median $1,189 among those who did). This doctor's total is higher than 92% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US infectious disease doctors.
Payments to Michael Manoles do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Daniel Dulas, MD
Infectious Disease
CMS Open Payments· $132,189 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$132,189
Total received
34
Transactions
6
Paying companies
Top paying companies
Among the 3,681 infectious disease doctors we've analyzed, about 83% received any industry payment (median $1,189 among those who did). This doctor's total is higher than 97% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US infectious disease doctors.
Payments to Daniel Dulas do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Anil Poulose, MD
Infectious Disease
CMS Open Payments· $22,183 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$22,183
Total received
18
Transactions
3
Paying companies
Top paying companies
Among the 3,681 infectious disease doctors we've analyzed, about 83% received any industry payment (median $1,189 among those who did). This doctor's total is higher than 91% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US infectious disease doctors.
Payments to Anil Poulose do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Alok Sharma, MD
Infectious Disease
CMS Open Payments· $39,082 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$39,082
Total received
10
Transactions
5
Paying companies
Top paying companies
Among the 3,681 infectious disease doctors we've analyzed, about 83% received any industry payment (median $1,189 among those who did). This doctor's total is higher than 93% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US infectious disease doctors.
Payments to Alok Sharma do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Allison Hall, MD
Infectious Disease
CMS Open Payments· $96.62 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$96.62
Total received
1
Transactions
1
Paying companies
Top paying companies
Among the 3,681 infectious disease doctors we've analyzed, about 83% received any industry payment (median $1,189 among those who did). This doctor's total is on the lower end — around the 24th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US infectious disease doctors.
Payments to Allison Hall do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Anna Taylor, MD
Infectious Disease
CMS Open Payments· $17.99 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$17.99
Total received
1
Transactions
1
Paying companies
Top paying companies
Among the 3,681 infectious disease doctors we've analyzed, about 83% received any industry payment (median $1,189 among those who did). This doctor's total is on the lower end — around the 18th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US infectious disease doctors.
Payments to Anna Taylor do not imply any wrongdoing. Many are meals, education, or research support.